J.P. Morgan Life Sciences Private Capital Adds Dashyant Dhanak, Ph.D. as Venture Partner
2 Articles
2 Articles
J.P. Morgan Life Sciences Private Capital Adds Dashyant Dhanak, Ph.D. as Venture Partner
J.P. Morgan Life Sciences Private Capital, the NYC-based life sciences venture and growth equity arm within J.P. Morgan Asset Management, announced the appointment of Dashyant Dhanak, Ph.D., as Venture Partner. Dr. Dhanak is a seasoned pharmaceutical research and development expert with over 30 years of experience. Most recently, he was the Chief Scientific Officer at Deciphera […] The post J.P. Morgan Life Sciences Private Capital Adds Dashyant…
Encoding Life Sciences Expertise with AI
As an industry, life sciences is now looking towards technological change to leverage investments made during the past few years. In fact, according to Trinity’s TGaS Advisors, the proportion of surveyed companies reporting that they have completed proof of concept or are using GenAI at an enterprise level for commercial, medical, or customer operations surged from less than 10% Source
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium